Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#167 / 200 Total
LFVN - Lifevantage Corporation - Stock Price Chart
TickerLFVN [NASD]
CompanyLifevantage Corporation
CountryUSA
IndustryPackaged Foods
Market Cap86.11MEPS (ttm)0.28
P/E24.26EPS this Y170.83%
Forward P/E9.69EPS next Y7.69%
PEG2.02EPS past 5Y-13.19%
P/S0.42EPS next 5Y12.00%
P/B3.21EPS Q/Q59.75%
Dividend2.04%Sales Q/Q-10.23%
Insider Own20.66%Inst Own29.21%
Insider Trans-0.17%Inst Trans9.86%
Short Float0.78%EarningsMay 02/a
Analyst Recom1.00Target Price7.00
Avg Volume35.29K52W Range3.79 - 8.69
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, Canine Health, and Buy Products. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cunningham KristenChief Sales OfficerApr 01 '24Option Exercise0.003,001094,480Apr 03 05:13 PM
Boyster JulieChief Marketing OfficerApr 01 '24Option Exercise0.003,6680101,885Apr 03 05:13 PM
Aure CarlChief Financial OfficerApr 01 '24Option Exercise0.002,4010129,409Apr 03 05:12 PM
Fife Steven RPresident and CEOApr 01 '24Option Exercise0.0020,2340655,077Apr 03 05:14 PM
Neufeld AlissaGeneral CounselApr 01 '24Option Exercise0.002,668089,761Apr 03 05:13 PM
ZKH - ZKH Group Ltd ADR - Stock Price Chart
TickerZKH [NYSE]
CompanyZKH Group Ltd ADR
CountryChina
IndustryInternet Retail
Market Cap1.45BEPS (ttm)-0.85
P/E-EPS this Y263.43%
Forward P/E12.46EPS next Y539.46%
PEG-EPS past 5Y-
P/S1.18EPS next 5Y-
P/B4.03EPS Q/Q63.33%
Dividend-Sales Q/Q6.47%
Insider Own8.87%Inst Own0.52%
Insider Trans0.00%Inst Trans-
Short Float0.07%EarningsMay 21/b
Analyst Recom1.00Target Price21.38
Avg Volume47.66K52W Range11.25 - 21.91
ZKH Group Ltd. engages in the business-to-business trading and services of industrial products through its platform. It provides maintenance, repair, and operations (MRO) procurement and management services for customers and offers digital solutions for participants along the industry value chain. The company was founded by Long Chen in 2014 and is headquartered in Shanghai, China.
DAO - Youdao Inc ADR - Stock Price Chart
TickerDAO [NYSE]
CompanyYoudao Inc ADR
CountryChina
IndustryEducation & Training Services
Market Cap114.27MEPS (ttm)-0.65
P/E-EPS this Y84.40%
Forward P/E34.62EPS next Y209.47%
PEG-EPS past 5Y-14.78%
P/S0.15EPS next 5Y-
P/B-EPS Q/Q366.91%
Dividend-Sales Q/Q0.24%
Insider Own8.41%Inst Own42.07%
Insider Trans0.00%Inst Trans-0.63%
Short Float1.34%EarningsMay 23/b
Analyst Recom1.25Target Price5.93
Avg Volume136.99K52W Range2.94 - 5.64
Youdao, Inc engages in the provision of learning content, applications, and solutions. It operates through the following segments: Learning Services, Smart Devices, and Online Marketing Services segments. The Learning Services segment offers online courses such as Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The Smart Devices segment sells gadgets which include smart pens, listening pods, pocket translators, and dictionaries. The Online Marketing Services segment is involved in the development of different formats of advertising solutions. The company was founded in March 2006 and is headquartered Hangzhou, China.
NVCT - Nuvectis Pharma Inc - Stock Price Chart
TickerNVCT [NASD, RUT]
CompanyNuvectis Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap112.91MEPS (ttm)-1.37
P/E-EPS this Y9.79%
Forward P/E-EPS next Y-9.30%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B8.05EPS Q/Q8.40%
Dividend-Sales Q/Q-
Insider Own60.93%Inst Own8.53%
Insider Trans0.09%Inst Trans28.35%
Short Float13.17%EarningsMay 07/b
Analyst Recom1.00Target Price22.00
Avg Volume105.00K52W Range5.92 - 18.65
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENTSUR RONChairman & CEOMay 14 '24Buy6.741,94013,0763,246,424May 15 09:16 AM
BENTSUR RONChairman & CEOMay 10 '24Buy6.402,00012,8003,244,484May 13 08:51 AM
Shemesh ShayChief Dev. & Ops. OfficerMay 10 '24Buy6.321,1137,0341,493,068May 13 08:47 AM
Poradosu EnriqueChief Science & Business OffMay 10 '24Buy6.295003,1451,504,319May 13 08:49 AM
BENTSUR RONChairman & CEOMar 18 '24Buy10.295,00051,4503,242,484Mar 19 08:00 AM
BRTX - BioRestorative Therapies Inc - Stock Price Chart
TickerBRTX [NASD]
CompanyBioRestorative Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap8.80MEPS (ttm)-3.54
P/E-EPS this Y39.04%
Forward P/E-EPS next Y3.60%
PEG-EPS past 5Y77.95%
P/S58.67EPS next 5Y-
P/B0.53EPS Q/Q49.37%
Dividend-Sales Q/Q421.62%
Insider Own19.19%Inst Own12.81%
Insider Trans28.45%Inst Trans2.02%
Short Float3.10%EarningsMay 14/a
Analyst Recom1.00Target Price10.50
Avg Volume559.67K52W Range1.20 - 7.13
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silva FranciscoVP of Research and DevelopmentApr 09 '24Buy1.256,6008,250155,759Apr 10 05:16 PM
Silva FranciscoVP of Research and DevelopmentApr 08 '24Buy1.161,7081,979149,159Apr 10 05:16 PM
Broadrick Dale10% OwnerFeb 09 '24Buy1.3286,041113,574477,972Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.3483,626112,059447,045Feb 09 08:00 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.2573,95992,449391,931Feb 12 09:26 AM
FATE - Fate Therapeutics Inc - Stock Price Chart
TickerFATE [NASD, RUT]
CompanyFate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap443.94MEPS (ttm)-1.92
P/E-EPS this Y-14.49%
Forward P/E-EPS next Y1.21%
PEG-EPS past 5Y-6.65%
P/S68.51EPS next 5Y-
P/B1.04EPS Q/Q-146.52%
Dividend-Sales Q/Q-96.74%
Insider Own10.68%Inst Own95.14%
Insider Trans-0.08%Inst Trans-2.86%
Short Float21.77%EarningsMay 09/a
Analyst Recom2.50Target Price6.81
Avg Volume2.66M52W Range1.63 - 8.83
Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dulac Edward J IIIChief Financial OfficerMar 04 '24Sale7.772,44719,013101,479Mar 05 04:24 PM
Dulac Edward J IIIChief Financial OfficerJan 29 '24Sale5.001,8499,245103,926Jan 30 04:01 PM
Wolchko J ScottPresident and CEOJan 09 '24Sale4.3714,39162,889371,248Jan 10 04:29 PM
Valamehr BahramChief R&D OfficerJan 09 '24Sale4.3811,27149,367158,069Jan 10 04:30 PM
TAHL CINDYGeneral Counsel and SecretaryJan 09 '24Sale4.3710,87447,519142,361Jan 10 04:30 PM
DDL - Dingdong (Cayman) Ltd ADR - Stock Price Chart
TickerDDL [NYSE]
CompanyDingdong (Cayman) Ltd ADR
CountryChina
IndustryGrocery Stores
Market Cap323.31MEPS (ttm)-0.02
P/E-EPS this Y263.76%
Forward P/E10.37EPS next Y153.66%
PEG-EPS past 5Y51.93%
P/S0.12EPS next 5Y3.27%
P/B5.54EPS Q/Q117.39%
Dividend-Sales Q/Q-4.31%
Insider Own19.88%Inst Own11.59%
Insider Trans0.00%Inst Trans3.66%
Short Float1.42%EarningsMay 13/b
Analyst Recom2.00Target Price2.04
Avg Volume442.54K52W Range1.07 - 3.40
May-14-24 01:27AM Q1 2024 Dingdong (Cayman) Ltd Earnings Call (Thomson Reuters StreetEvents)
May-13-24 10:53AM DDL Stock Earnings: Dingdong (Cayman) Beats Revenue for Q1 2024 (InvestorPlace) -15.74%
05:30AM Dingdong (Cayman) Limited Announces First Quarter 2024 Financial Results (PR Newswire)
Apr-29-24 07:00AM Dingdong to Report First Quarter 2024 Financial Results on May 13, 2024 (PR Newswire) +6.35%
Apr-19-24 05:00PM Dingdong Files Its Annual Report on Form 20-F (PR Newswire) +6.48%
Feb-29-24 04:36AM Dingdong (Cayman) Limited Announces Fourth Quarter 2023 Financial Results (PR Newswire) -10.16%
Feb-22-24 07:00AM Dingdong to Report Fourth Quarter 2023 Financial Results on February 29, 2024 (PR Newswire)
Jan-29-24 08:00AM Dingdong Announces US$20.0 Million Share Repurchase Program (PR Newswire) +12.31%
Dec-26-23 06:00AM Dingdong Announces the Appointment of CFO and CHRO (PR Newswire)
Nov-16-23 09:22PM Q3 2023 Dingdong (Cayman) Ltd Earnings Call (Thomson Reuters StreetEvents) -7.32%
Dingdong (Cayman) Ltd. operates as an on-demand e-commerce company. The firm provides users with fresh produce, meat and seafood, and other daily necessities through a convenient and excellent shopping experience supported by an extensive self-operated frontline fulfillment grid. It also provides other daily necessities to grow into a one-stop online shopping destination in China for consumers to make purchases for their daily lives. The Company was founded by Liang Changlin in October 2018 and is headquartered in Shanghai, China.
AUID - authID Inc - Stock Price Chart
TickerAUID [NASD]
CompanyauthID Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap69.84MEPS (ttm)-18.34
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y10.66%
P/S225.28EPS next 5Y-
P/B6.43EPS Q/Q80.39%
Dividend-Sales Q/Q315.73%
Insider Own18.32%Inst Own14.08%
Insider Trans17.35%Inst Trans-41.48%
Short Float4.87%EarningsMay 15/a
Analyst Recom-Target Price-
Avg Volume26.44K52W Range3.21 - 13.63
authID, Inc. engages in the delivery of secure, mobile, and biometric identity solutions. It operates through the Verified Authentication Business segment. The company was founded by Thomas R Snoke on September 21, 2011 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Garchik Stephen Jeffrey10% OwnerApr 23 '24Buy6.8512,00082,2001,163,096Apr 25 08:00 AM
Garchik Stephen Jeffrey10% OwnerApr 12 '24Buy7.6910,50080,7451,151,096Apr 15 05:15 PM
Garchik Stephen Jeffrey10% OwnerJan 31 '24Buy9.405,70053,5801,140,596Feb 01 07:00 PM
Garchik Stephen Jeffrey10% OwnerJan 30 '24Buy9.102,50022,7501,134,896Jan 30 08:25 PM
Garchik Stephen Jeffrey10% OwnerJan 25 '24Buy9.401,0009,4001,132,396Jan 26 06:08 AM
BYSI - BeyondSpring Inc - Stock Price Chart
TickerBYSI [NASD]
CompanyBeyondSpring Inc
CountryUSA
IndustryBiotechnology
Market Cap104.38MEPS (ttm)-0.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y25.94%
P/S59.64EPS next 5Y-
P/B-EPS Q/Q52.99%
Dividend-Sales Q/Q87.78%
Insider Own39.17%Inst Own2.38%
Insider Trans0.00%Inst Trans-20.48%
Short Float10.00%Earnings-
Analyst Recom2.00Target Price1.25
Avg Volume214.99K52W Range0.65 - 4.00
May-16-24 08:00AM BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics (GlobeNewswire)
May-03-24 07:00AM BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics (GlobeNewswire)
Apr-29-24 05:30PM BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results (GlobeNewswire)
05:30PM BeyondSpring Files 2023 Annual Report on Form 20-F (GlobeNewswire)
Mar-25-24 07:00AM BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer (GlobeNewswire) +11.22%
Feb-26-24 08:00AM BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements (GlobeNewswire) +9.17%
Jan-10-24 03:00PM BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K (GlobeNewswire)
Dec-18-23 04:30PM BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements (GlobeNewswire)
Nov-07-23 07:00AM BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors (GlobeNewswire)
Oct-31-23 08:00AM BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin's Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models (GlobeNewswire)
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.
GLOB - Globant S.A. - Stock Price Chart
TickerGLOB [NYSE]
CompanyGlobant S.A.
CountryLuxembourg
IndustryInformation Technology Services
Market Cap7.25BEPS (ttm)3.82
P/E43.93EPS this Y11.17%
Forward P/E22.17EPS next Y18.60%
PEG-EPS past 5Y21.45%
P/S3.31EPS next 5Y-
P/B4.14EPS Q/Q21.38%
Dividend-Sales Q/Q20.88%
Insider Own2.23%Inst Own92.27%
Insider Trans0.00%Inst Trans5.06%
Short Float2.44%EarningsMay 16/a
Analyst Recom1.62Target Price224.28
Avg Volume473.03K52W Range141.88 - 251.50
May-17-24Reiterated Needham Buy $275 → $200
Globant SA engages in the provision of information technology services. It includes application development, testing, infrastructure management, and application maintenance. The company was founded by Martin Migoya, Martin Gonzalo Umaran, Guibert Andres Englebienne, and Nestor Augusto Nocetti in 2003 and is headquartered in Luxembourg.
110121314151617181920